Healthcare >> Analyst Interviews >> September 30, 2021
Interview with the CEO: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)
Vincent Angotti is CEO and a member of the board of directors at AcelRx Pharmaceuticals, Inc. Earlier, he was CEO of XenoPort, Inc., a biopharmaceutical company focused on the development of treatments for neuropathic pain and other neurological disorders. Prior to that, Mr. Angotti was Senior Vice President of Sales and Marketing at Reliant Pharmaceuticals. He is a graduate of Cornell University and received an MBA, with honors, from Columbia University. Profile
Word count: 3,136
TWST: Could you tell me about the company?
Mr. Angotti: AcelRx is a company that is developing and commercializing innovative therapies for